Amgen Inc. v. Aurobindo Pharma Limited et al
| Amgen Inc. and KAI Pharmaceuticals, Inc. |
| Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, AuroMedics Pharma LLC, MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited |
| 1:2022cv00037 |
| January 10, 2022 |
| US District Court for the District of Delaware |
| Maryellen Noreika |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on February 3, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 17
SCHEDULING ORDER: These cases (C.A. No. 21-662 and C.A. No. 22-37) are consolidated for all purposes, including trial. Joinder of Parties due by 9/1/2022. Amended Pleadings due by 9/1/2022. Fact Discovery completed by 9/29/2022. Opening Expert Reports due by 5/11/2023. Rebuttal Expert Reports due by 6/29/2023. Reply Expert Reports due by 7/27/2023. Expert Discovery due by 9/14/2023. Claim Construction Opening Brief served by 1/19/2023. Claim Construction Answering Brief served by 2/9/2023. Claim Construction Reply Brief served by 2/23/2023. Claim Construction Surreply Brief served by 3/9/2023. Joint Claim Construction Brief filed by 3/16/2023. A Markman Hearing is set for 4/19/2023 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 11/6/2023 at 11:00 AM in Courtroom 4A before Judge Maryellen Noreika. A 5- day Bench Trial is set for 11/13/2023 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 2/3/2022. (dlw)
|
| Case associated with lead case: Create association to 1:21-cv-00662-MN. (dlw) |
| Filing 16 PROPOSED ORDER -- [Proposed] Revised Scheduling Order -- by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
|
Filing 15
SO ORDERED re #14 Stipulation of Voluntary Dismissal without Prejudice as to MSN Life Sciences Private Limited. Party MSN Life Sciences Private Limited terminated. Signed by Judge Maryellen Noreika on 1/20/2022. (dlw)
|
| Filing 14 STIPULATION of Voluntary Dismissal without Prejudice as to MSN Life Sciences Private Limited by Amgen Inc., KAI Pharmaceuticals, Inc. (Jacobs, Karen) Modified on 1/20/2022 (dlw). |
| Filing 13 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. MSN Pharmaceuticals Inc. served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Filing 12 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. MSN Life Sciences Private Limited served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Filing 11 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. MSN Laboratories Private Limited served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Filing 10 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. Eugia Pharma Specialties Limited served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Filing 9 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. AuroMedics Pharma LLC served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Filing 8 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. Aurobindo Pharma USA Inc. served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Filing 7 SUMMONS Returned Executed by Amgen Inc., KAI Pharmaceuticals, Inc.. Aurobindo Pharma Limited served on 1/19/2022, answer due 2/9/2022. (Streifthau-Livizos, Michelle) |
| Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms) |
| Filing 6 Summons Issued with Magistrate Consent Notice attached as to AuroMedics Pharma LLC on 1/10/2022; Aurobindo Pharma Limited on 1/10/2022; Aurobindo Pharma USA Inc. on 1/10/2022; Eugia Pharma Specialties Limited on 1/10/2022; MSN Laboratories Private Limited on 1/10/2022; MSN Life Sciences Private Limited on 1/10/2022; MSN Pharmaceuticals Inc. on 1/10/2022. (Attachments: #1 Summons Issued Aurobindon Pharma Limited, #2 Summons Issued AuroMedics, #3 Summons Issued Eugia, #4 Summons Issued MSN Labs, #5 Summons Issued MSN Life, #6 Summons Issued MSN Pharma)(mal) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for KAI Pharmaceuticals, Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (mal) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,162,500. (mal) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: see attached. Date of Expiration of Patent: 6/27/2034.Thirty Month Stay Deadline: 8/7/2024. (mal) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Filing 1 COMPLAINT filed against AuroMedics Pharma LLC, Aurobindo Pharma Limited, Aurobindo Pharma USA Inc., Eugia Pharma Specialties Limited, MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3778066.) - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mal) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
